Pharmaceutical Analytical Testing Outsourcing Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Pharmaceutical Analytical Testing Outsourcing Market Report is Segmented by Services (Bioanalytical Testing, Method Development and Validation, Stability Testing, and Other Services), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The Market Values are Provided (in USD Million) for the Above Segments.

Pharmaceutical Analytical Testing Outsourcing Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Pharmaceutical Analytical Testing Outsourcing Market Size

Pharmaceutical Analytical Testing Outsourcing Market (2025 - 2030)
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
CAGR 8.70 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Pharmaceutical Analytical Testing Outsourcing Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Pharmaceutical Analytical Testing Outsourcing Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Pharmaceutical Analytical Testing Outsourcing Market Analysis

The Pharmaceutical Analytical Testing Outsourcing Market is expected to register a CAGR of 8.70% during the forecast period.

  • COVID-19 significantly impacted pharmaceutical analytical testing outsourcing due to the rise in the testing process to develop novel therapies for the disease. This has led to a rise in approvals from regulatory agencies on clinical trial sites by decreasing the time for the approval process. For instance, according to the article published in the European Pharmaceutical Review by Dr. Ronan Brow in March 2021, during the outbreak, the pharmaceutical sector and regulatory authorities worked closely together to create and provide diagnostic tests, treatments, and vaccinations at breakneck speed. In addition, the sector had seen a shift in site permissions from local to centralized.
  • Similarly, the initiative by key market players, such as agreements, was expected to increase market growth. For instance, in November 2021, Alcami Corporation, Inc. signed a master laboratory services agreement with Novavax. With this agreement, Novavax immediately secured full-time equivalent (FTE) resources to provide analytical testing support for its recombinant nanoparticle protein-based COVID-19 vaccine candidate with Matrix-M adjuvant. Thus, all these factors are likely to have a positive impact on the market growth over the pandemic phase.
  • Further, the factors driving the growth of this market include a rise in research and development expenditures, increasing focus on regulation, safety, and quality, pricing benefits of outsourcing, and a rise in the demand for biosimilars and biopharmaceutical products as well as for analytical drugs, availability of advanced analytical testing techniques such as hyphenated techniques; kinetic method of analysis, electrochemical techniques, among others.
  • Rising acquisitions and partnerships among pharmaceutical analytical testing outsourcing providers will drive the growth of this market. For instance, in December 2021, PharmaLex Group, a provider of specialist services for the pharmaceutical, biotech, and MedTech sectors, merged with Pharmasol, a life sciences corporation specializing in pharmacovigilance IT and business support. In addition, in December 2021, SGS SA acquired Quay Pharmaceuticals Limited (Quay Pharma), a UK-based provider of innovative formulation research and development services. With this acquisition, SGS will add Quay Pharmaceuticals services to its comprehensive portfolio of analytical services.
  • Furthermore, the rising demand for biosimilars and biopharmaceuticals will drive the market's growth significantly. For instance, the study published in the Iranian Journal of Medical Sciences in September 2021 stated that it is expected that the development of new biosimilars would save consumers up to USD 250 billion and make biological therapies more accessible to an extra 1.2 million patients by 2025. This increases the availability of such products to patients with chronic conditions and provides a more affordable option for those who previously had to discontinue therapy or rely on less effective medications. Such an increase in biosimilar manufacturing will increase the outsourcing of drug testing services, thereby boosting market growth. Therefore, owing to the aforementioned factors, the market is expected to grow over the forecast period.
  • However, a rise in the reliance on the performance of unstable outsourced manufacturing organizations, an increase in the concerns regarding the privacy/theft of confidential data for manufacturing pharmaceuticals, and varied outsourcing expenditures by companies, among others, are expected to hamper the growth of the market studied.

Pharmaceutical Analytical Testing Outsourcing Industry Overview

The market for pharmaceutical analytical testing outsourcing is moderately competitive. The market is expected to grow due to factors such as a rise in key market strategies by the market players, such as partnerships with pharmaceutical and biopharmaceutical companies and mergers and acquisitions among the players. Some of the major players operating in this market include SGS SA, Labcorp (Toxikon, Inc.), Eurofins Scientific, Pace Analytical Services, Inc., Intertek Group Plc, WuXi AppTec, and Boston Analytical, among others.

Pharmaceutical Analytical Testing Outsourcing Market Leaders

  1. SGS SA

  2. Labcorp (Toxikon, Inc)

  3. Eurofins Scientific

  4. Pace Analytical Services, Inc.

  5. Intertek Group Plc

  6. *Disclaimer: Major Players sorted in no particular order
Pharmaceutical Analytical Testing Outsourcing Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Pharmaceutical Analytical Testing Outsourcing Market News

  • April 2022: Bruker Corporation acquired Optimal Industrial Automation and Technologies, a leader in pharma and biopharma process analytical technology (PAT), pharma manufacturing automation, and Quality Assurance (QA) software and systems integration based in the United Kingdom.
  • February 2022: The Center for Breakthrough Medicines (CBM) formed a strategic alliance with BioAnalysis LLC (BIA) to provide CBM's clients with direct access to BIA's advanced testing capabilities, including characterization of viral vectors using BIA's proprietary sedimentation velocity approach to analytical ultracentrifugation, as well as other advanced biophysical methods and analytics.

Pharmaceutical Analytical Testing Outsourcing Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing focus on Regulation, Safety and Quality
    • 4.2.2 Pricing Benefits of Outsourcing
    • 4.2.3 Rise in the Demand for Biosimilars and Biopharmaceutical Products as well as for Analytical Drugs
  • 4.3 Market Restraints
    • 4.3.1 Increase in the Concerns Regarding Privacy/Theft of Confidential Data of Manufacturing Pharmaceuticals
    • 4.3.2 Varied Outsourcing Expenditures by Companies
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market size in USD)

  • 5.1 By Services
    • 5.1.1 Bioanalytical Testing
    • 5.1.1.1 Clinical
    • 5.1.1.2 Non-clinical
    • 5.1.2 Method Development and Validation
    • 5.1.2.1 Extractable & Leachable
    • 5.1.2.2 Impurity Method
    • 5.1.2.3 Technical Consulting
    • 5.1.2.4 Other Method Development and Validations
    • 5.1.3 Stability Testing
    • 5.1.3.1 Drug Substance
    • 5.1.3.2 Stability Indicating Method Validation
    • 5.1.3.3 Accelerated Stability Testing
    • 5.1.3.4 Photostability Testing
    • 5.1.3.5 Other Stability Testings
    • 5.1.4 Other Services
  • 5.2 By End-User
    • 5.2.1 Pharmaceutical And Biopharmaceutical Companies
    • 5.2.2 Contract Manufactuing Organizations
    • 5.2.3 Other End-Users
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 SGS SA
    • 6.1.2 Labcorp (Toxikon, Inc)
    • 6.1.3 Eurofins Scientific
    • 6.1.4 Pace Analytical Services, Inc.
    • 6.1.5 Intertek Group Plc
    • 6.1.6 Thermofischer Scientific (Pharmaceutical Product Development, LLC )
    • 6.1.7 WuXi AppTec
    • 6.1.8 Boston Analytical
    • 6.1.9 Charles River Laboratories International, Inc
    • 6.1.10 West Pharmaceutical Services Inc.
    • 6.1.11 Element Group (Exova Group PLC)
    • 6.1.12 Merck KGaA
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Pharmaceutical Analytical Testing Outsourcing Industry Segmentation

Pharmaceutical analytical testing outsourcing encompasses all aspects of the pharmaceutical and therapies manufacturing, testing, and validation processes. This includes verifying pharmaceutical ingredients, compounds, and manufacturing procedures needed for medication development. These outsourcing services are provided by outsourcing companies that are focused on such services.

The pharmaceutical analytical testing outsourcing market is segmented by services (bioanalytical testing, method development and validation, stability testing, and other services), end-user (pharmaceutical and biopharmaceutical companies, contract manufacturing organizations, and other end-users), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD) for the above segments.

By Services Bioanalytical Testing Clinical
Non-clinical
Method Development and Validation Extractable & Leachable
Impurity Method
Technical Consulting
Other Method Development and Validations
Stability Testing Drug Substance
Stability Indicating Method Validation
Accelerated Stability Testing
Photostability Testing
Other Stability Testings
Other Services
By End-User Pharmaceutical And Biopharmaceutical Companies
Contract Manufactuing Organizations
Other End-Users
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Pharmaceutical Analytical Testing Outsourcing Market Research FAQs

What is the current Pharmaceutical Analytical Testing Outsourcing Market size?

The Pharmaceutical Analytical Testing Outsourcing Market is projected to register a CAGR of 8.70% during the forecast period (2025-2030)

Who are the key players in Pharmaceutical Analytical Testing Outsourcing Market?

SGS SA, Labcorp (Toxikon, Inc), Eurofins Scientific, Pace Analytical Services, Inc. and Intertek Group Plc are the major companies operating in the Pharmaceutical Analytical Testing Outsourcing Market.

Which is the fastest growing region in Pharmaceutical Analytical Testing Outsourcing Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Pharmaceutical Analytical Testing Outsourcing Market?

In 2025, the North America accounts for the largest market share in Pharmaceutical Analytical Testing Outsourcing Market.

What years does this Pharmaceutical Analytical Testing Outsourcing Market cover?

The report covers the Pharmaceutical Analytical Testing Outsourcing Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Pharmaceutical Analytical Testing Outsourcing Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Pharmaceutical Analytical Testing Outsourcing Industry Report

Statistics for the 2025 Pharmaceutical Analytical Testing Outsourcing market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Pharmaceutical Analytical Testing Outsourcing analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.